Glenn HearsonApr 1, 2021Nottingham Asthma Centre Newsletter: Spring 2021The Spring 2021 Asthma Newsletter is now out. NAC_Newsletter_Spring_2021.pdfDownload PDF • 1.12MB
Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)
Study to evaluate the safety, pharmacokinetics and pharmacodynamics of Selnofast in participants with moderate to severe Asthma
Comments